Gold-induced aplastic pancytopenia: 14-month survival through multiple transfusions.
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001803:Blood Transfusion; D004112:Dimercaprol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006046:Gold / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D050607:Organogold Compounds; D009942:Organometallic Compounds; D010198:Pancytopenia / Q000139:chemically induced* / Q000628:therapy; D017713:Platelet Transfusion; D020005:Propanols; D013438:Sulfhydryl Compounds
D000893:Anti-Inflammatory Agents; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds; D004112:Dimercaprol; D006046:Gold; C013394:aurotioprol